Breast cancer drug shows potential in patients with skin metastases
Researchers are reporting clinical activity with the investigational oral compound tucatinib, used...
Researchers are reporting clinical activity with the investigational oral compound tucatinib, used...
Summary After its failed attempts for a merger with Allergan and AstraZeneca to bolster its drug...
Lung cancer trial results showed a win for Merck and a loss for Bristol-Myers. (tycoon101 –...
The Food and Drug Administration (FDA) requires a new drug’s manufacturer to present...